Literature DB >> 22981171

Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion.

.   

Abstract

Intracytoplasmic sperm injection, while typically effective for overcoming low or absent fertilization in couples with a clear abnormality of semen parameters, is frequently utilized in combination with assisted reproductive technologies for other etiologies of infertility in the presence of normal semen parameters. This committee opinion provides a critical review of the literature, where available, to identify situations where this may or may not be of benefit.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22981171     DOI: 10.1016/j.fertnstert.2012.08.026

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  38 in total

1.  Conventional in vitro fertilization maybe yields more available embryos than intracytoplasmic sperm injection for patients with no indications for ICSI.

Authors:  Li Ming; Chen Yuan; Zhao Ping; Liu Ping; Qiao Jie
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Pre-implantation genetic diagnosis-should we use ICSI for all?

Authors:  Baruch Feldman; Adva Aizer; Masha Brengauz; Keren Dotan; Jacob Levron; Eyal Schiff; Raoul Orvieto
Journal:  J Assist Reprod Genet       Date:  2017-06-13       Impact factor: 3.412

3.  Clinical outcomes following ICSI cycles using surgically recovered sperm and the impact of maternal age: 2004-2015 SART CORS registry.

Authors:  A M Mahesan; S Sadek; V Moussavi; T Vazifedan; A Majeed; T Cunningham; S Oehninger; S Bocca
Journal:  J Assist Reprod Genet       Date:  2018-06-20       Impact factor: 3.412

Review 4.  Application of microfluidic technologies to human assisted reproduction.

Authors:  Gary D Smith; Shuichi Takayama
Journal:  Mol Hum Reprod       Date:  2017-04-01       Impact factor: 4.025

5.  Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.

Authors:  Sara Crawford; Sheree L Boulet; Jennifer F Kawwass; Denise J Jamieson; Dmitry M Kissin
Journal:  Fertil Steril       Date:  2016-11-11       Impact factor: 7.329

6.  Association of assisted reproductive technology (ART) treatment and parental infertility diagnosis with autism in ART-conceived children.

Authors:  D M Kissin; Y Zhang; S L Boulet; C Fountain; P Bearman; L Schieve; M Yeargin-Allsopp; D J Jamieson
Journal:  Hum Reprod       Date:  2014-12-17       Impact factor: 6.918

7.  Live birth rates using conventional in vitro fertilization compared to intracytoplasmic sperm injection in Bologna poor responders with a single oocyte retrieved.

Authors:  Ioannis A Sfontouris; Efstratios M Kolibianakis; George T Lainas; Ram Navaratnarajah; Basil C Tarlatzis; Trifon G Lainas
Journal:  J Assist Reprod Genet       Date:  2015-03-11       Impact factor: 3.412

8.  Assisted hatching and intracytoplasmic sperm injection are not associated with improved outcomes in assisted reproduction cycles for diminished ovarian reserve: an analysis of cycles in the United States from 2004 to 2011.

Authors:  Samantha F Butts; Carter Owen; Monica Mainigi; Suneeta Senapati; David B Seifer; Anuja Dokras
Journal:  Fertil Steril       Date:  2014-07-30       Impact factor: 7.329

9.  A prospective randomized study to evaluate the effect of hyaluronic acid sperm selection on the intracytoplasmic sperm injection outcome of patients with unexplained infertility having normal semen parameters.

Authors:  Gaurav Majumdar; Abha Majumdar
Journal:  J Assist Reprod Genet       Date:  2013-10-02       Impact factor: 3.412

10.  Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A).

Authors:  Katherine L Palmerola; Sally F Vitez; Selma Amrane; Catha P Fischer; Eric J Forman
Journal:  J Assist Reprod Genet       Date:  2018-10-25       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.